Search Results

XL-888 50mg 50mg  | Purity Not Available

Adooq Bioscience

XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.

More Information Supplier Page

XL-888 5mg 5mg  | Purity Not Available

Adooq Bioscience

XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.

More Information Supplier Page

XL-888 25mg 25mg  | Purity Not Available

Adooq Bioscience

XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.

More Information Supplier Page

XL-888 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.

More Information Supplier Page

XL-888 10mg 10mg  | Purity Not Available

Adooq Bioscience

XL888 is an orally bioavailable, ATP-competitive, small-molecule inhibitor of heat shock protein 90 (Hsp90) with potential antineoplastic activity.

More Information Supplier Page

GW842166X 10mM * 1mL in DMSO 10mM * 1mL in DMSO  | Purity Not Available

Adooq Bioscience

GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain

More Information Supplier Page

GW842166X 25mg 25mg  | Purity Not Available

Adooq Bioscience

GW842166X is a selective non-cannabinoid CB2 receptor agonist, which is undergoing clinical development as a novel oral treatment for inflammatory pain

More Information Supplier Page